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INTRODUCTION
Clear cell sarcoma (CCS), also known as mela-
noma of soft parts, typically presents in the deep soft
tissues of the lower extremity, in close proximity to
tendons, fascias, or aponeuroses. Young adults are
preferentially affected and the clinical course is often
marked by regional and distant metastases with a
reported 5-year survival rate of 50 -60%. Most CCS
show immunoreactivity for melanoma markers, such
as HMB45, and contain melanosomes. Indeed, most
CCS share a melanocytic gene expression signature
with melanomas. However, CCS are also geneti-
cally distinct from melanomas, as they lack BRAF
mutations and show, in most cases, a recurrent chro-
mosomal translocation t(12 ; 22)(q13 ; q12), result-
ing in the fusion of EWS gene on 22q12 with the ac-
tivating transcription factor -1 gene (ATF1) on 12q13
(1, 5).
Primary CCSs of the gastrointestinal tract are
rare. Gastrointestinal CCS includes a histologic vari-
ant rich in osteoclast - type giant cells which uni-
formly express S100 protein. As a result of its rar-
ity in the gastrointestinal tract, the differential diag-
nosis of CCS in this site includes more common
mesenchymal of neuroectodermal neoplasms, such
as gastrointestinal stromal tumors, Shwannoma, car-
cinoid, or metastatic melanoma (1-4).
We report a case of early -stage Clear cell sar-
coma (CCS) of the small intestine detected by 18F -
fluoro-2 -deoxy D-glucose Positron Emission To-
mography/Computed Tomography (FDG-PET/CT)
during comprehensive examination of an inflamma-
tory reaction.
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CASE REPORT
The patient was a nursing student in her early
twenties with no particular chief complaint. During
practical training, she noted that her erythrocyte
sedimentation rate (ESR)was elevated, and visited
the Department of Internal Medicine of our hospi-
tal one month later. At the first examination, her C-
reactive protein (CRP) was 3.7 mg/dl (normal0.3
mg/dl), and ESR 80 mm/h (normal range, 3 -15
mm/h). For the differential diagnosis of infection,
collagen disease and malignant tumor, plain chest
CT and a planar gallium whole-body scan were per-
formed, but no causative lesions were identified. Dur-
ing subsequent follow-up, her inflammatory reac-
tion persisted (CRP 6-9 mg/dl, ESR 100-130 mm/
h). Nine months after the first examination at the
Department of Internal Medicine at our hospital,
she developed common cold symptoms and a low-
grade fever, and showed a persistently high CRP ;
therefore, she was admitted to the same department
for further evaluation.
On admission, her temperature was 37.6, blood
pressure 120/80 mmHg, and pulse 84 bpm and
regular. The palpebral conjunctivae were anemic.
The throat was not red. No cervical lymphadenopa-
thy was noted. The heart and breath sounds were
normal. The abdomen was flat and soft, with no ten-
derness. No edema or joint pain was present. She
experienced no weight loss. No motor or sensory
deficit was identified.
On admission, blood tests showed microcytic ane-
mia, thrombocytosis and elevated CRP (15.5 mg/
dl) which meant chronic inflammatory reaction.
However rheumatoid factor (RF) was slightly ele-
vated, and antinuclear antibody was positive, it was
difficult to determine the cause on inflammatory re-
action collagen disease. Contrast CT of the chest,
abdomen and pelvic region was performed, which
suggested small lymph node lesions around the pel-
vic arteries (Fig. 1). Although the small intestinal le-
sion existed at that time, we could not detect it. The
patient did not have much fat in the abdominal cav-
ity, therefore, the organs were in close proximity to
each other, and the small intestinal lesion was en-
hanced similar to the normal intestine. Therefore, it
was difficult to detect the lesion only by contrast CT.
The mild common cold symptoms noted on ad-
mission suggested the presence of infection, but an-
tibiotic administration did not improve the low-grade
fever or CRP level. To exclude blood disorders,
bone marrow aspiration was performed, but no
abnormalities were found. The inflammatory reac-
tion had increased for about 1 year, but various ex-
aminations revealed no abnormalities we could de-
tect. Thus, to search for infectious foci and neoplas-
tic disease again, we performed FDG-PET/CT.
FDG-PET showed an abnormal, mass-like up-
take (*Standarized Uptake Value (SUV)max 10) on
the right side of the pelvic cavity and another nodu-
lar uptake (SUVmax 3.3) anterior to the sacral bone
(Fig. 2). The abnormal uptake in the right pelvic
cavity corresponded on CT to a structure that con-
sisted of soft - tissue-density areas mixed with low-
density areas (Fig. 3). The presacral uptake corre-
sponded to soft - tissue densities on CT (Fig. 4). A
second look at the admission CT scans in compari-
son with the abnormal uptake in the right pelvic cav-
ity on FDG-PET showed a solid, contrast-enhanced,
mass- like structure in the intestinal lumen or wall,
at about the same level (Fig. 1a). The presacral up-
take corresponded on CT to soft - tissue densities
that apparently surrounded the blood vessels, which
suggested soft - tissue tumors including malignant
lymphoma (Fig. 1b). However, the SUVmax of 3.3
was not high enough to confidently diagnose ma-
lignancy. The presacral uptake might be reactive
lymph nodes caused by long-term inflammatory
a
b
Fig. 1. (a) Upon admission, contrast CT suggested lymph node
enlargement around the arteries anterior to the sacral bone
(arrow). (b) Arrow indicates the neoplastic lesion that was diffi-
cult to detect upon admission.
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reaction.
Barium contrast radiography of the small intestine
revealed an approximately 2.5 cm submucosal mass
with a surface depression and good passage of bar-
ium through this region (Fig. 5).
Laparoscopic, segmental small - intestine resection
was performed about 1 month after admission. Dur-
ing surgery, a 4 cm tumor was found about 150 cm
proximal to the end of the ileum. In addition to the
presacral lymph nodes observed on FDG-PET/CT,
many of the mesenteric lymph nodes were enlarged.
Some of these nodes were submitted for frozen sec-
tion diagnosis, but no malignant lesions were found.
Frozen section examination of the small intestinal
tumor suggested malignant lymphoma. Based on
these findings, some of the lymph nodes with
FDG uptake were collected, and small intestinal re-
section was performed.
The resected specimen contained a 3 cm tumor
with a surface ulcer that corresponded to the depres-
sion on Barium contrast radiography of the small
intestine. On the cut surface, the tumor involved
the muscular layer, but left the serosa intact (Fig.
6). Histopathological examination revealed a sub-
mucosal, nodular lesion composed of short, spin-
dle - shaped cells with clear cytoplasm. As many as
7-9 mitotic figures per high-power field (magnifica-
tion400) were seen, which suggested malignancy
(Fig. 7b). Osteoclast - like, multinucleated giant cells
were present among tumor cells (Fig. 7a). Since the
origin of the tumor could not be identified by H-E
staining alone, immunostaining was performed. As
Fig. 2. FDG-PET maximum intensity projection (MIP) images
showed a strong, mass- like uptake on the right side of the pel-
vic cavity and a nodular uptake anterior to the sacral bone. Low-
level uptake in the right pelvic cavity corresponded to the ovary
on CT.
a b c
Fig. 3. (a) FDG-PET revealed abnormal uptake (SUVmax 10) in the right pelvic cavity. (b) Uptake corresponded on CT to a struc-
ture that consisted of soft - tissue-density areas mixed with low-density areas, which suggested a small intestinal lesion. (c) FDG-
PET/CT image resulting from (a) superimposed on (b).
a b c
Fig. 4. (a) FDG-PET showed uptake (SUVmax 3.3) anterior to the sacral bone. (b) Uptake corresponded to soft - tissue density on
CT. (c) FDG-PET/CT image resulting from (a) superimposed on (b).
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a result, the tumor cells were positive for S-100
protein (Fig. 8a). Reverse Transcriptase-Polymerase
Chain Reaction (RT-PCR) was performed, suggest-
ing a translocation resulting in EWS-ATF1 gene fu-
sion (Fig. 8b).
These findings led to the diagnosis of CCS. No
malignant features were observed in the surgically
resected lymph nodes with increased FDG uptake,
as detected by FDG-PET/CT.
FDG-PET/CT, performed 3 months after sur-
gery, revealed no abnormal uptake suggestive of
metastasis or recurrence (Fig. 9). The presacral
lymph nodes, which had exhibited abnormal uptake
before surgery, were reduced in size, and showed
no detectable uptake, which suggested that the pre-
operative uptake was due to inflammation (Fig. 10).
After surgery, the ESR and CRP returned to normal.
Currently, 2 years after surgery, the patient is free
from recurrence and metastasis.
Fig. 6. The resected specimen contained a 3 cm tumor with
a surface ulcer. On the cut surface, the tumor involved the mus-
cular coat, but left the serosa intact.
Fig. 5. Small intestinal fluoroscopy revealed an 2.5 cm submu-
cosal mass with a surface depression in the ileum.
a
b
Fig. 7. (a) Histopathological image of the tumor at low mag-
nification (100). Osteoclast - like, multinucleated giant cells were
present among tumor cells. (b) At high magnification (400), a
submucosal, nodular lesion composed of short, spindle-shaped
cells with clear cytoplasm was observed.
a
b
Fig. 8. (a) Histopathological immunostaining view at high mag-
nification (400). The tumor cells were positive for S-100 pro-
tein. (b) RT-PCR showed EWS-ATF1 fusion gene.
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DISCUSSION
The incidence of CCS of gastrointestinal tract ori-
gin is much lower, in the small intestine, large in-
testine and stomach, in decreasing order of fre-
quency. The tumor grows transmurally, and is re-
portedly often associated with ulceration and lymph
node metastasis. Molecular detection of the EWS/
AFT1 fusion gene establishes the diagnosis (1 -4).
Comin, et al. (5) reported 16 patients who were di-
agnosed with gastrointestinal CCS. Their mean age
was 39 years, and the tumor was found frequently
in women, mostly in the small intestine, had a mean
diameter of 3 cm, and was frequently associated
with ulceration and full-thickness invasion. In many
patients, CCS starts with disturbed passage of stools
and weight loss, but laboratory tests, including
blood tests, reveal no abnormalities in some pa-
tients. Local lymph node metastasis or mesenteric
dissemination is observed in about half of the pa-
tients at the time of diagnosis, and liver metasta-
sis, peritoneal dissemination, pancreatic metastasis,
or lung metastasis in most patients. The present
CCS arose in the small intestine of a young woman,
similar to previously reported cases, but the lesion
was localized in the small intestine, with no metas-
tasis, as demonstrated by biopsies of the enlarged
lymph nodes. In this case, a planar gallium whole -
body scan was negative at the first examination.
Contrast CT of the chest, abdomen and pelvic re-
gion performed after 1 year, but it was difficult to
detect the small intestinal lesion. The patient did not
have much fat in the abdominal cavity, therefore all
the organs were in close proximity to each other,
and the lesion was enhanced similarly to normal in-
testine. To establish the reason for the increased
inflammatory reaction, we performed FDG-PET/
CT, which revealed obvious abnormal uptake. Nei-
ther FDG-PET/CT nor contrast CT contributed to
the diagnosis, but FDG-PET/CT was useful for de-
tecting the lesion. Hereafter, FDG-PET/CT might
help to detect the small intestinal lesion such as
gastrointestinal stromal tumors, carcinoid, or me-
tastatic melanoma, which is difficult to distinguish
from normal intestine as our case. Besides, FDG-
PET/CT might be helpful in detecting postopera-
tive recurrence of CCS of gastrointestinal origin.
Our literature search revealed reports of the use-
fulness of FDG-PET/CT in the detection of post-
operative recurrence of CCS that developed in the
soft tissue of bone (6), but no detection of CCS of
gastrointestinal origin.
Fig. 9. FDG-PET MIP image obtained 3 months after sur-




Fig. 10. Axial view images of FDG PET/CT after 3 months
after surgery.(a) Presacral lymph nodes, which had exhibited
abnormal uptake before surgery, showed no detectable uptake.
(b) Upon CT, the presacral lymph nodes were reduced in size.
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In conclusion, we report a patient with small intes-
tinal CCS that was detected by FDG-PET/CT. Gas-
trointestinal CCS is a very rare, malignant tumor
that is often advanced at the time of diagnosis. In
this patient, FDG-PET/CT, performed during com-
prehensive examination of a prolonged inflamma-
tory reaction, clearly visualized the lesion, which was
difficult to detect by other imaging techniques, and
therefore had a marked clinical impact.
*Supplementary explanation of standardized uptake
value (SUV).
SUV=tissue concentlation (KBq/ml)/injected
FDG dose (KBq)/body weight (g)
A popular usage of SUVs is their capability in
helping to distinguish between benign and malig-
nant lesions. For example, a study might find an
SUV of 2.5 as appropriate for separating certain be-
nign and malignant lesions. Caution, however, must
be exercised using such a cutoff outside of the in-
stitution and the application for which it was deter-
mined (7).
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